Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Sainz

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2024
RNF212B E3 ligase is essential for crossover designation and maturation during male and female meiosis in the mouseYazmine B Condezo, Raquel Sainz-Urruela, Laura Gomez-H, et al.
International Journal of Molecular Sciences|September 28, 2024
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple SclerosisMaría Inmaculada Domínguez-Mozo, Ignacio Casanova, Enric Monreal, et al.
Frontiers in Immunology|December 22, 2025
New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosisAlexander Rodero-Romero, María Domínguez-Mozo, Enric Monreal, et al.
Frontiers in Immunology|August 25, 2025
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosisAlexander Rodero-Romero, José Ignacio Fernández-Velasco, Enric Monreal, et al.
Therapeutic Advances in Neurological Disorders|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective studyJuan Luis Chico-Garcia, Moisés Morales de la Prida, Almudena Boix Lago, et al.
Brain : a Journal of Neurology|August 5, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosisEnric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente, et al.
Frontiers in Immunology|November 28, 2024
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosisFernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Frontiers in Immunology|January 3, 2025
Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosisFernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2024
RNF212B E3 ligase is essential for crossover designation and maturation during male and female meiosis in the mouseYazmine B Condezo, Raquel Sainz-Urruela, Laura Gomez-H, et al.
International Journal of Molecular Sciences|September 28, 2024
Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple SclerosisMaría Inmaculada Domínguez-Mozo, Ignacio Casanova, Enric Monreal, et al.
Frontiers in Immunology|December 22, 2025
New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosisAlexander Rodero-Romero, María Domínguez-Mozo, Enric Monreal, et al.
Frontiers in Immunology|August 25, 2025
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosisAlexander Rodero-Romero, José Ignacio Fernández-Velasco, Enric Monreal, et al.
Therapeutic Advances in Neurological Disorders|May 15, 2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective studyJuan Luis Chico-Garcia, Moisés Morales de la Prida, Almudena Boix Lago, et al.
Brain : a Journal of Neurology|August 5, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosisEnric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente, et al.
Frontiers in Immunology|November 28, 2024
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosisFernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Frontiers in Immunology|January 3, 2025
Corrigendum: Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosisFernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Pageof 4